Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-18

Clinical Trial Update: A Study to Evaluate Concomitant Perfluorohexyloctane Use With Contact Lens Wear [Phase 4]

View source ↗

Summary

A Phase 4 study conducted by Bausch & Lomb evaluated the concomitant use of perfluorohexyloctane with contact lenses for dry eye and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perfluorohexyloctane (perfluorohexyloctane)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye | Phase 4 | Status: COMPLETED